fondaparinux sodium
Generic: fondaparinux sodium
Labeler: dr. reddy's laboratories limitedDrug Facts
Product Profile
Brand Name
fondaparinux sodium
Generic Name
fondaparinux sodium
Labeler
dr. reddy's laboratories limited
Dosage Form
INJECTION
Routes
Active Ingredients
fondaparinux sodium 7.5 mg/.6mL
Manufacturer
Identifiers & Regulatory
Product NDC
55111-680
Product ID
55111-680_2a3f9c6b-885b-843d-9cc8-3eb67395fbda
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA091316
Listing Expiration
2026-12-31
Marketing Start
2011-07-14
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
55111680
Hyphenated Format
55111-680
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
fondaparinux sodium (source: ndc)
Generic Name
fondaparinux sodium (source: ndc)
Application Number
ANDA091316 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 7.5 mg/.6mL
Packaging
- 2 SYRINGE in 1 CARTON (55111-680-02) / .6 mL in 1 SYRINGE (55111-680-11)
- 10 SYRINGE in 1 CARTON (55111-680-10) / .6 mL in 1 SYRINGE (55111-680-11)
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["SUBCUTANEOUS"], "spl_id": "2a3f9c6b-885b-843d-9cc8-3eb67395fbda", "openfda": {"unii": ["X0Q6N9USOZ"], "rxcui": ["861356", "861360", "861363", "861365"], "spl_set_id": ["49e0d7bc-3f49-849b-c77c-98682d1c0d19"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 SYRINGE in 1 CARTON (55111-680-02) / .6 mL in 1 SYRINGE (55111-680-11)", "package_ndc": "55111-680-02", "marketing_start_date": "20110714"}, {"sample": false, "description": "10 SYRINGE in 1 CARTON (55111-680-10) / .6 mL in 1 SYRINGE (55111-680-11)", "package_ndc": "55111-680-10", "marketing_start_date": "20110714"}], "brand_name": "Fondaparinux Sodium", "product_id": "55111-680_2a3f9c6b-885b-843d-9cc8-3eb67395fbda", "dosage_form": "INJECTION", "pharm_class": ["Factor Xa Inhibitor [EPC]", "Factor Xa Inhibitors [MoA]"], "product_ndc": "55111-680", "generic_name": "Fondaparinux Sodium", "labeler_name": "Dr. Reddy's Laboratories Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fondaparinux Sodium", "active_ingredients": [{"name": "FONDAPARINUX SODIUM", "strength": "7.5 mg/.6mL"}], "application_number": "ANDA091316", "marketing_category": "ANDA", "marketing_start_date": "20110714", "listing_expiration_date": "20261231"}